对OSA的CPAP疗法及其对各种心血管疾病的影响
Kajol Kumari1, Joud Khalaf2, Liyan Jehad Sawan3
1From the Ghulam Muhammad Mahar Medical College, Sukkur, Pakistan.
Cardiology in review
|January 14, 2025
概括
阻塞性睡眠呼吸暂停 (OSA) 导致疲劳和心血管问题. 持续的正气道压力 (CPAP) 治疗有帮助,但患者的坚持仍然是一个需要更多研究的挑战.
科学领域:
- 睡眠医学 睡眠医学
- 心脏病学 心脏病学
- 代谢健康 代谢健康
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 是一种常见的,严重的疾病,导致睡眠障碍,疲劳和代谢问题.
- OSA显著增加了心血管疾病的风险,包括高血压,心力衰竭和中风.
- 尽管有CPAP等有效的治疗方法,但由于合规性挑战,OSA往往被诊断不足和治疗不足.
研究的目的:
- 审查OSA对心血管和代谢健康的影响.
- 讨论持续正气道压力 (CPAP) 治疗OSA的有效性和局限性.
- 突出需要改善患者的坚持和进一步的研究.
主要方法:
- 对OSA对心血管和代谢系统的影响的文献综述.
- 分析当前的治疗策略,重点关注CPAP.
- 检查影响患者遵守CPAP治疗的因素.
主要成果:
- OSA与心血管并发症和代谢障碍密切相关.
- 在OSA患者中,CPAP疗法有效降低了心血管疾病.
- 患者不遵守CPAP是治疗的重要障碍,通常是由于不适和不便.
结论:
- CPAP疗法为OSA患者提供了显著的心血管益处.
- 解决患者的服从和坚持是优化OSA治疗结果的关键.
- 需要进一步的研究来改善CPAP的坚持和了解长期的心血管影响.
相关概念视频
Sleep Apnea
125
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
125
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
168
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
168
Other Pulmonary Disorders
801
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
801
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
134
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
134
Mechanical Ventilation III: Noninvasive Ventilation
76
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
76


